These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28122351)

  • 1. CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.
    Zheng H; Jiang WH; Tian T; Tan HS; Chen Y; Qiao GL; Han J; Huang SY; Yang Y; Li S; Wang ZG; Gao R; Ren H; Xing H; Ni JS; Wang LH; Ma LJ; Zhou WP
    Oncotarget; 2017 Mar; 8(12):18872-18884. PubMed ID: 28122351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
    Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
    Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
    Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
    Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
    Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.
    Lv X; Zhao F; Huo X; Tang W; Hu B; Gong X; Yang J; Shen Q; Qin W
    Med Oncol; 2016 Jul; 33(7):70. PubMed ID: 27262566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SESN2 correlates with advantageous prognosis in hepatocellular carcinoma.
    Chen S; Yan W; Lang W; Yu J; Xu L; Xu X; Liu Y; Bao H
    Diagn Pathol; 2017 Jan; 12(1):13. PubMed ID: 28118855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.
    Zhang HX; Jiang SS; Zhang XF; Zhou ZQ; Pan QZ; Chen CL; Zhao JJ; Tang Y; Xia JC; Weng DS
    Oncotarget; 2015 Oct; 6(33):34800-17. PubMed ID: 26430962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
    Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
    Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
    Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
    BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
    Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
    BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CLN3 contributes to tumour progression and predicts poor prognosis in hepatocellular carcinoma.
    Xu Y; Wang H; Zeng Y; Tian Y; Shen Z; Xie Z; Chen F; Sun L; Shu R; Li PP; Chen C; Yu J; Wang K; Luo H
    Surg Oncol; 2019 Mar; 28():180-189. PubMed ID: 30851897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High USP22 expression indicates poor prognosis in hepatocellular carcinoma.
    Tang B; Tang F; Li B; Yuan S; Xu Q; Tomlinson S; Jin J; Hu W; He S
    Oncotarget; 2015 May; 6(14):12654-67. PubMed ID: 25909224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma.
    Srivastava S; Thakkar B; Yeoh KG; Ho KY; Teh M; Soong R; Salto-Tellez M
    Virchows Arch; 2015 May; 466(5):541-8. PubMed ID: 25742908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
    Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
    Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells.
    Liang L; Li Q; Huang LY; Li DW; Wang YW; Li XX; Cai SJ
    Int J Oncol; 2014 Aug; 45(2):659-66. PubMed ID: 24859471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma.
    Ou D; Yang H; Hua D; Xiao S; Yang L
    Oncotarget; 2015 Jul; 6(19):17379-90. PubMed ID: 25978032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.